<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36875095</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1093208</StartPage><MedlinePgn>1093208</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1093208</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1093208</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is an autoimmune illness marked by the loss of immune tolerance and the production of autoantibodies against nucleic acids and other nuclear antigens (Ags). B lymphocytes are important in the immunopathogenesis of SLE. Multiple receptors control abnormal B-cell activation in SLE patients, including intrinsic Toll-like receptors (TLRs), B-cell receptors (BCRs), and cytokine receptors. The role of TLRs, notably TLR7 and TLR9, in the pathophysiology of SLE has been extensively explored in recent years. When endogenous or exogenous nucleic acid ligands are recognized by BCRs and internalized into B cells, they bind TLR7 or TLR9 to activate related signalling pathways and thus govern the proliferation and differentiation of B cells. Surprisingly, TLR7 and TLR9 appear to play opposing roles in SLE B cells, and the interaction between them is still poorly understood. In addition, other cells can enhance TLR signalling in B cells of SLE patients by releasing cytokines that accelerate the differentiation of B cells into plasma cells. Therefore, the delineation of how TLR7 and TLR9 regulate the abnormal activation of B cells in SLE may aid the understanding of the mechanisms of SLE and provide directions for TLR-targeted therapies for SLE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wen, Zhang, Wu, Liu, Fan, Han, Zhang, Ma, Chu and Shi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Luyao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xinfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Rongzeng</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Basic Medical Sciences, Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Office of Research &amp; Innovation, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhibo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Cong-Qiu</ForeName><Initials>CQ</Initials><AffiliationInfo><Affiliation>Division of Arthritis and Rheumatic Diseases, Oregon Health &amp; Science University and VA Portland Health Care System, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Xiaofei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051199">Toll-Like Receptor 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051217">Toll-Like Receptor 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011947">Receptors, Antigen, B-Cell</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009696">Nucleic Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051199" MajorTopicYN="N">Toll-Like Receptor 7</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051217" MajorTopicYN="N">Toll-Like Receptor 9</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011947" MajorTopicYN="N">Receptors, Antigen, B-Cell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009696" MajorTopicYN="Y">Nucleic Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">TLR signaling</Keyword><Keyword MajorTopicYN="N">TLR7</Keyword><Keyword MajorTopicYN="N">TLR9</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">targeted therapies</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36875095</ArticleId><ArticleId IdType="pmc">PMC9975558</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1093208</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365:2110&#x2013;21. doi:&#xa0;10.1056/NEJMra1100359</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive b cells. Eur J Immunol (2006) 36:810&#x2013;6. doi:&#xa0;10.1002/eji.200535744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200535744</ArticleId><ArticleId IdType="pubmed">16541472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR9 stimulation drives na&#xef;ve b cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol (2007) 37:2205&#x2013;13. doi:&#xa0;10.1002/eji.200636984</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200636984</ArticleId><ArticleId IdType="pubmed">17621369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampropoulou V, Hoehlig K, Roch T, Neves P, G&#xf3;mez EC, Sweenie CH, et al. . TLR-activated b cells suppress T cell-mediated autoimmunity. J Immunol (2008) 180:4763&#x2013;73. doi:&#xa0;10.4049/jimmunol.180.7.4763</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.7.4763</ArticleId><ArticleId IdType="pubmed">18354200</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovics K, Battin C, Leitner J, Geiselhart S, Paster W, St&#xf6;ckl J, et al. . A highly sensitive cell-based TLR reporter platform for the specific detection of bacterial TLR ligands. Front Immunol (2022) 12:817604. doi:&#xa0;10.3389/fimmu.2021.817604</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.817604</ArticleId><ArticleId IdType="pmc">PMC8786796</ArticleId><ArticleId IdType="pubmed">35087538</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell (2020) 180:1044&#x2013;66. doi:&#xa0;10.1016/j.cell.2020.02.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.041</ArticleId><ArticleId IdType="pmc">PMC9358771</ArticleId><ArticleId IdType="pubmed">32164908</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev (2007) 220:251&#x2013;69. doi:&#xa0;10.1111/j.1600-065X.2007.00572.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2007.00572.x</ArticleId><ArticleId IdType="pubmed">17979852</ArticleId></ArticleIdList></Reference><Reference><Citation>Green NM, Marshak-Rothstein A. Toll-like receptor driven b cell activation in the induction of systemic autoimmunity. Semin Immunol (2011) 23:106&#x2013;12. doi:&#xa0;10.1016/j.smim.2011.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2011.01.016</ArticleId><ArticleId IdType="pmc">PMC3070769</ArticleId><ArticleId IdType="pubmed">21306913</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumilas N, Corneth OBJ, Lehmann CHK, Schmitt H, Cunz S, Cullen JG, et al. . Siglec-h-deficient mice show enhanced type I IFN responses, but do not develop autoimmunity after influenza or LCMV infections. Front Immunol (2021) 12:698420. doi:&#xa0;10.3389/fimmu.2021.698420</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.698420</ArticleId><ArticleId IdType="pmc">PMC8419311</ArticleId><ArticleId IdType="pubmed">34497606</ArticleId></ArticleIdList></Reference><Reference><Citation>Garimella MG, He C, Chen G, Li QZ, Huang X, Karlsson MCI. The b cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors. J Autoimmun (2021) 117:102582. doi:&#xa0;10.1016/j.jaut.2020.102582</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102582</ArticleId><ArticleId IdType="pubmed">33296829</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity (2006) 25:417&#x2013;28. doi:&#xa0;10.1016/j.immuni.2006.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.07.013</ArticleId><ArticleId IdType="pubmed">16973389</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. . Distinct effector b cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity (2018) 49:725&#x2013;39.e6. doi:&#xa0;10.1016/j.immuni.2018.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6217820</ArticleId><ArticleId IdType="pubmed">30314758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilstra JS, John S, Gordon RA, Leibler C, Kashgarian M, Bastacky S, et al. . B cell-intrinsic TLR9 expression is protective in murine lupus. J Clin Invest (2020) 130:3172&#x2013;87. doi:&#xa0;10.1172/jci132328</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci132328</ArticleId><ArticleId IdType="pmc">PMC7260024</ArticleId><ArticleId IdType="pubmed">32191633</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JL, Scholz JL, Marshak-Rothstein A, Cancro MP. Molecular pattern recognition in peripheral b cell tolerance: lessons from age-associated b cells. Curr Opin Immunol (2019) 61:33&#x2013;8. doi:&#xa0;10.1016/j.coi.2019.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2019.07.008</ArticleId><ArticleId IdType="pubmed">31446338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gies V, Schickel JN, Jung S, Joublin A, Glauzy S, Knapp AM, et al. . Impaired TLR9 responses in b cells from patients with systemic lupus erythematosus. JCI Insight (2018) 3:e96795. doi:&#xa0;10.1172/jci.insight.96795</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.96795</ArticleId><ArticleId IdType="pmc">PMC5922279</ArticleId><ArticleId IdType="pubmed">29515028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindhava VJ, Oropallo MA, Moody K, Naradikian M, Higdon LE, Zhou L, et al. . A TLR9-dependent checkpoint governs b cell responses to DNA-containing antigens. J Clin Invest (2017) 127:1651&#x2013;63. doi:&#xa0;10.1172/jci89931</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci89931</ArticleId><ArticleId IdType="pmc">PMC5409796</ArticleId><ArticleId IdType="pubmed">28346226</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibler C, John S, Elsner RA, Thomas KB, Smita S, Joachim S, et al. . Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus. Nat Immunol (2022) 23:1457&#x2013;69. doi:&#xa0;10.1038/s41590-022-01310-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01310-2</ArticleId><ArticleId IdType="pmc">PMC9561083</ArticleId><ArticleId IdType="pubmed">36151396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Wang J, Kumar V, Karnell JL, Naiman B, Gross PS, et al. . IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ b cells in SLE. Nat Commun (2018) 9:1758. doi:&#xa0;10.1038/s41467-018-03750-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03750-7</ArticleId><ArticleId IdType="pmc">PMC5931508</ArticleId><ArticleId IdType="pubmed">29717110</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, et al. . Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus. J Exp Med (2005) 202:1131&#x2013;9. doi:&#xa0;10.1084/jem.20050914</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050914</ArticleId><ArticleId IdType="pmc">PMC2213213</ArticleId><ArticleId IdType="pubmed">16230478</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds JM, Dong C. Toll-like receptor regulation of effector T lymphocyte function. Trends Immunol (2013) 34:511&#x2013;9. doi:&#xa0;10.1016/j.it.2013.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2013.06.003</ArticleId><ArticleId IdType="pubmed">23886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Chodisetti SB, Fike AJ, Domeier PP, Singh H, Choi NM, Corradetti C, et al. . Type II but not type I IFN signaling is indispensable for TLR7-promoted development of autoreactive b cells and systemic autoimmunity. J Immunol (2020) 204:796&#x2013;809. doi:&#xa0;10.4049/jimmunol.1901175</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1901175</ArticleId><ArticleId IdType="pmc">PMC7002260</ArticleId><ArticleId IdType="pubmed">31900342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive b cell responses to RNA-related antigens due to TLR7 gene duplication. Science (2006) 312:1669&#x2013;72. doi:&#xa0;10.1126/science.1124978</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1124978</ArticleId><ArticleId IdType="pubmed">16709748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol (2015) 11:329&#x2013;41. doi:&#xa0;10.1038/nrneph.2015.33</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.33</ArticleId><ArticleId IdType="pubmed">25825084</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, et al. . A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA (2006) 103:9970&#x2013;5. doi:&#xa0;10.1073/pnas.0603912103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603912103</ArticleId><ArticleId IdType="pmc">PMC1502563</ArticleId><ArticleId IdType="pubmed">16777955</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S, et al. . TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol (2018) 3:eaap8855. doi:&#xa0;10.1126/sciimmunol.aap8855</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aap8855</ArticleId><ArticleId IdType="pubmed">29374079</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M, Mej&#xed;a JE, Chaumeil J, Gu&#xe9;ry JC. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation. Semin Immunopathol (2019) 41:153&#x2013;64. doi:&#xa0;10.1007/s00281-018-0712-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0712-y</ArticleId><ArticleId IdType="pubmed">30276444</ArticleId></ArticleIdList></Reference><Reference><Citation>Syrett CM, Sierra I, Beethem ZT, Dubin AH, Anguera MC. Loss of epigenetic modifications on the inactive X chromosome and sex-biased gene expression profiles in b cells from NZB/W F1 mice with lupus-like disease. J Autoimmun (2020) 107:102357. doi:&#xa0;10.1016/j.jaut.2019.102357</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102357</ArticleId><ArticleId IdType="pmc">PMC7237307</ArticleId><ArticleId IdType="pubmed">31780316</ArticleId></ArticleIdList></Reference><Reference><Citation>Odhams CA, Roberts AL, Vester SK, Duarte CST, Beales CT, Clarke AJ, et al. . Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in systemic lupus erythematosus. Nat Commun (2019) 10:2164. doi:&#xa0;10.1038/s41467-019-10106-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10106-2</ArticleId><ArticleId IdType="pmc">PMC6520347</ArticleId><ArticleId IdType="pubmed">31092820</ArticleId></ArticleIdList></Reference><Reference><Citation>Raafat II, El Guindy N, Shahin RMH, Samy LA, El Refai RM. Toll-like receptor 7 gene single nucleotide polymorphisms and the risk for systemic lupus erythematosus: a case-control study. Z Rheumatol (2018) 77:416&#x2013;20. doi:&#xa0;10.1007/s00393-017-0283-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00393-017-0283-7</ArticleId><ArticleId IdType="pubmed">28243744</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Ortiz H, Vel&#xe1;zquez-Cruz R, Espinosa-Rosales F, Jim&#xe9;nez-Morales S, Baca V, Orozco L. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis (2010) 69:1861&#x2013;5. doi:&#xa0;10.1136/ard.2009.124313</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.124313</ArticleId><ArticleId IdType="pubmed">20525845</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Qiu J, Yin L, Hong X, Dai W, Tang D, et al. . Integrated analysis of competing endogenous RNA networks in peripheral blood mononuclear cells of systemic lupus erythematosus. J Transl Med (2021) 19:362. doi:&#xa0;10.1186/s12967-021-03033-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03033-8</ArticleId><ArticleId IdType="pmc">PMC8380341</ArticleId><ArticleId IdType="pubmed">34419106</ArticleId></ArticleIdList></Reference><Reference><Citation>Klonowska-Szymczyk A, Wolska A, Robak T, Cebula-Obrzut B, Smolewski P, Robak E. Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Med Inflamm (2014) 2014:381418. doi:&#xa0;10.1155/2014/381418</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/381418</ArticleId><ArticleId IdType="pmc">PMC3955595</ArticleId><ArticleId IdType="pubmed">24692849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Marken J, Chen J, Tran VB, Li QZ, Li M, et al. . High TLR7 expression drives the expansion of CD19+CD24hiCD38hi transitional b cells and autoantibody production in SLE patients. Front Immunol (2019) 10:1243. doi:&#xa0;10.3389/fimmu.2019.01243</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01243</ArticleId><ArticleId IdType="pmc">PMC6559307</ArticleId><ArticleId IdType="pubmed">31231380</ArticleId></ArticleIdList></Reference><Reference><Citation>Giltiay NV, Chappell CP, Sun X, Kolhatkar N, Teal TH, Wiedeman AE, et al. . Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 b cells. J Exp Med (2013) 210:2773&#x2013;89. doi:&#xa0;10.1084/jem.20122798</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20122798</ArticleId><ArticleId IdType="pmc">PMC3832927</ArticleId><ArticleId IdType="pubmed">24145511</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh ER, Pisitkun P, Voynova E, Deane JA, Scott BL, Caspi RR, et al. . Dual signaling by innate and adaptive immune receptors is required for TLR7-induced b-cell-mediated autoimmunity. Proc Natl Acad Sci USA (2012) 109:16276&#x2013;81. doi:&#xa0;10.1073/pnas.1209372109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1209372109</ArticleId><ArticleId IdType="pmc">PMC3479588</ArticleId><ArticleId IdType="pubmed">22988104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SH, Lee H, Yamamoto M, Jones LA, Dayalan J, Hopkins R, et al. . B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J Immunol (2012) 189:5786&#x2013;96. doi:&#xa0;10.4049/jimmunol.1202195</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202195</ArticleId><ArticleId IdType="pmc">PMC3544945</ArticleId><ArticleId IdType="pubmed">23150717</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown GJ, Ca&#xf1;ete PF, Wang H, Medhavy A, Bones J, Roco JA, et al. . TLR7 gain-of-function genetic variation causes human lupus. Nature (2022) 605:349&#x2013;56. doi:&#xa0;10.1038/s41586-022-04642-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04642-z</ArticleId><ArticleId IdType="pmc">PMC9095492</ArticleId><ArticleId IdType="pubmed">35477763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, et al. . Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: A new model of systemic lupus erythematosus. Arthritis Rheumatol (2014) 66:694&#x2013;706. doi:&#xa0;10.1002/art.38298</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38298</ArticleId><ArticleId IdType="pubmed">24574230</ArticleId></ArticleIdList></Reference><Reference><Citation>Celhar T, Lu HK, Benso L, Rakhilina L, Lee HY, Tripathi S, et al. . TLR7 protein expression in mild and severe lupus-prone models is regulated in a leukocyte, genetic, and IRAK4 dependent manner. Front Immunol (2019) 10:1546. doi:&#xa0;10.3389/fimmu.2019.01546</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01546</ArticleId><ArticleId IdType="pmc">PMC6636428</ArticleId><ArticleId IdType="pubmed">31354711</ArticleId></ArticleIdList></Reference><Reference><Citation>Meffre E, Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol (2008) 20:632&#x2013;8. doi:&#xa0;10.1016/j.coi.2008.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2008.09.001</ArticleId><ArticleId IdType="pubmed">18848883</ArticleId></ArticleIdList></Reference><Reference><Citation>Clingan JM, Matloubian M. B cell-intrinsic TLR7 signaling is required for optimal b cell responses during chronic viral infection. J Immunol (2013) 191:810&#x2013;8. doi:&#xa0;10.4049/jimmunol.1300244</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300244</ArticleId><ArticleId IdType="pmc">PMC3702634</ArticleId><ArticleId IdType="pubmed">23761632</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SW, Scharping NE, Kolhatkar NS, Khim S, Schwartz MA, Li QZ, et al. . Opposing impact of b cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J Immunol (2014) 192:4525&#x2013;32. doi:&#xa0;10.4049/jimmunol.1400098</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400098</ArticleId><ArticleId IdType="pmc">PMC4041708</ArticleId><ArticleId IdType="pubmed">24711620</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneparth A, Huang W, Bethunaickan R, Woods M, Sahu R, Arora S, et al. . TLR7 influences germinal center selection in murine SLE. PloS One (2015) 10:e0119925. doi:&#xa0;10.1371/journal.pone.0119925</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119925</ArticleId><ArticleId IdType="pmc">PMC4368537</ArticleId><ArticleId IdType="pubmed">25794167</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni C, Wong EB, Domeier PP, Khan TN, Satoh T, Akira S, et al. . B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers. J Immunol (2014) 193:4400&#x2013;14. doi:&#xa0;10.4049/jimmunol.1401720</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401720</ArticleId><ArticleId IdType="pmc">PMC4201954</ArticleId><ArticleId IdType="pubmed">25252960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, et al. . A new population of cells lacking expression of CD27 represents a notable component of the b cell memory compartment in systemic lupus erythematosus. J Immunol (2007) 178:6624&#x2013;33. doi:&#xa0;10.4049/jimmunol.178.10.6624</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.10.6624</ArticleId><ArticleId IdType="pubmed">17475894</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenks SA, Cashman KS, Woodruff MC, Lee FE, Sanz I. Extrafollicular responses in humans and SLE. Immunol Rev (2019) 288:136&#x2013;48. doi:&#xa0;10.1111/imr.12741</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12741</ArticleId><ArticleId IdType="pmc">PMC6422038</ArticleId><ArticleId IdType="pubmed">30874345</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol (2015) 15:160&#x2013;71. doi:&#xa0;10.1038/nri3795</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3795</ArticleId><ArticleId IdType="pubmed">25698678</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Mayeux J, Gutierrez T, Russell L, Getahun A, M&#xfc;ller J, et al. . A balance between b cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J Immunol (2014) 193:909&#x2013;20. doi:&#xa0;10.4049/jimmunol.1400666</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400666</ArticleId><ArticleId IdType="pmc">PMC4082765</ArticleId><ArticleId IdType="pubmed">24929000</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell L, John S, Cullen J, Luo W, Shlomchik MJ, Garrett-Sinha LA. Requirement for transcription factor Ets1 in b cell tolerance to self-antigens. J Immunol (2015) 195:3574&#x2013;83. doi:&#xa0;10.4049/jimmunol.1500776</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500776</ArticleId><ArticleId IdType="pmc">PMC4568556</ArticleId><ArticleId IdType="pubmed">26355157</ArticleId></ArticleIdList></Reference><Reference><Citation>Akatsu C, Shinagawa K, Numoto N, Liu Z, Ucar AK, Aslam M, et al. . CD72 negatively regulates b lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP. J Exp Med (2016) 213:2691&#x2013;706. doi:&#xa0;10.1084/jem.20160560</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160560</ArticleId><ArticleId IdType="pmc">PMC5110020</ArticleId><ArticleId IdType="pubmed">27810925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. . Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ b-cell population is important for the development of autoimmunity. Blood (2011) 118:1305&#x2013;15. doi:&#xa0;10.1182/blood-2011-01-331462</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-331462</ArticleId><ArticleId IdType="pmc">PMC3152497</ArticleId><ArticleId IdType="pubmed">21543762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, et al. . IFN&#x3b3; induces epigenetic programming of human T-bet(hi) b cells and promotes TLR7/8 and IL-21 induced differentiation. Elife (2019) 8:e41641. doi:&#xa0;10.7554/eLife.41641</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41641</ArticleId><ArticleId IdType="pmc">PMC6544433</ArticleId><ArticleId IdType="pubmed">31090539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancro MP. Age-associated b cells. Annu Rev Immunol (2020) 38:315&#x2013;40. doi:&#xa0;10.1146/annurev-immunol-092419-031130</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-092419-031130</ArticleId><ArticleId IdType="pubmed">31986068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice. Immunol Res (2013) 55:210&#x2013;6. doi:&#xa0;10.1007/s12026-012-8365-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-012-8365-8</ArticleId><ArticleId IdType="pmc">PMC3935605</ArticleId><ArticleId IdType="pubmed">22945807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricker E, Manni M, Flores-Castro D, Jenkins D, Gupta S, Rivera-Correa J, et al. . Altered function and differentiation of age-associated b cells contribute to the female bias in lupus mice. Nat Commun (2021) 12:4813. doi:&#xa0;10.1038/s41467-021-25102-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25102-8</ArticleId><ArticleId IdType="pmc">PMC8355159</ArticleId><ArticleId IdType="pubmed">34376664</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Kappler JW, Jacobelli J, Friedman RS, Marrack P. CD11c-expressing b cells are located at the T cell/B cell border in spleen and are potent APCs. J Immunol (2015) 195:71&#x2013;9. doi:&#xa0;10.4049/jimmunol.1500055</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500055</ArticleId><ArticleId IdType="pmc">PMC4475418</ArticleId><ArticleId IdType="pubmed">26034175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chodisetti SB, Fike AJ, Domeier PP, Choi NM, Soni C, Rahman ZSM. TLR7 negatively regulates B10 cells predominantly in an IFN&#x3b3; signaling dependent manner. Front Immunol (2020) 11:1632. doi:&#xa0;10.3389/fimmu.2020.01632</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01632</ArticleId><ArticleId IdType="pmc">PMC7399053</ArticleId><ArticleId IdType="pubmed">32849556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohto U, Shibata T, Tanji H, Ishida H, Krayukhina E, Uchiyama S, et al. . Structural basis of CpG and inhibitory DNA recognition by toll-like receptor 9. Nature (2015) 520:702&#x2013;5. doi:&#xa0;10.1038/nature14138</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14138</ArticleId><ArticleId IdType="pubmed">25686612</ArticleId></ArticleIdList></Reference><Reference><Citation>Machida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, et al. . Expression of toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol Dial Transplant (2010) 25:2530&#x2013;537. doi:&#xa0;10.1093/ndt/gfq058</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfq058</ArticleId><ArticleId IdType="pubmed">20181802</ArticleId></ArticleIdList></Reference><Reference><Citation>Elloumi N, Fakhfakh R, Abida O, Ayadi L, Marzouk S, Hachicha H, et al. . Relevant genetic polymorphisms and kidney expression of toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis. Clin Exp Immunol (2017) 190:328&#x2013;39. doi:&#xa0;10.1111/cei.13022</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13022</ArticleId><ArticleId IdType="pmc">PMC5680057</ArticleId><ArticleId IdType="pubmed">28763101</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao H, Zeng Q, Liang Y, Xiao C, Xie S, Xu X. Correlation between TLR9 expression and cytokine secretion in the clinical diagnosis of systemic lupus erythematosus. Mediators Inflammation (2015) 2015:710720. doi:&#xa0;10.1155/2015/710720</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/710720</ArticleId><ArticleId IdType="pmc">PMC4589624</ArticleId><ArticleId IdType="pubmed">26457008</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Zhao L, Ye Z, Ma H, Wang X, Jiang Z. Association of toll-like receptor 9 expression with prognosis of systemic lupus erythematosus. Exp Ther Med (2019) 17:3247&#x2013;54. doi:&#xa0;10.3892/etm.2019.7290</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7290</ArticleId><ArticleId IdType="pmc">PMC6434381</ArticleId><ArticleId IdType="pubmed">30937000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemazee DA, B&#xfc;rki K. Clonal deletion of b lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (1989) 337:562&#x2013;6. doi:&#xa0;10.1038/337562a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/337562a0</ArticleId><ArticleId IdType="pubmed">2783762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human b cell precursors. Science (2003) 301:1374&#x2013;7. doi:&#xa0;10.1126/science.1086907</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086907</ArticleId><ArticleId IdType="pubmed">12920303</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, et al. . Defective b cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med (2005) 201:703&#x2013;11. doi:&#xa0;10.1084/jem.20042251</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20042251</ArticleId><ArticleId IdType="pmc">PMC2212839</ArticleId><ArticleId IdType="pubmed">15738055</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol (2004) 4:249&#x2013;58. doi:&#xa0;10.1038/nri1329</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1329</ArticleId><ArticleId IdType="pubmed">15057783</ArticleId></ArticleIdList></Reference><Reference><Citation>Rookhuizen DC, DeFranco AL. Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses. Proc Natl Acad Sci USA (2014) 111:E3224&#x2013;33. doi:&#xa0;10.1073/pnas.1323985111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1323985111</ArticleId><ArticleId IdType="pmc">PMC4128120</ArticleId><ArticleId IdType="pubmed">25053813</ArticleId></ArticleIdList></Reference><Reference><Citation>Busconi L, Bauer JW, Tumang JR, Laws A, Perkins-Mesires K, Tabor AS, et al. . Functional outcome of b cell activation by chromatin immune complex engagement of the b cell receptor and TLR9. J Immunol (2007) 179:7397&#x2013;405. doi:&#xa0;10.4049/jimmunol.179.11.7397</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.11.7397</ArticleId><ArticleId IdType="pubmed">18025183</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med (2005) 202:321&#x2013;31. doi:&#xa0;10.1084/jem.20050338</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050338</ArticleId><ArticleId IdType="pmc">PMC2212997</ArticleId><ArticleId IdType="pubmed">16027240</ArticleId></ArticleIdList></Reference><Reference><Citation>Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate b cells by dual engagement of IgM and toll-like receptors. Nature (2002) 416:603&#x2013;7. doi:&#xa0;10.1038/416603a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/416603a</ArticleId><ArticleId IdType="pubmed">11948342</ArticleId></ArticleIdList></Reference><Reference><Citation>Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive b cells by CpG dsDNA. Immunity (2003) 19:837&#x2013;47. doi:&#xa0;10.1016/s1074-7613(03)00323-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1074-7613(03)00323-6</ArticleId><ArticleId IdType="pubmed">14670301</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med (2006) 203:553&#x2013;61. doi:&#xa0;10.1084/jem.20052438</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20052438</ArticleId><ArticleId IdType="pmc">PMC2118244</ArticleId><ArticleId IdType="pubmed">16492804</ArticleId></ArticleIdList></Reference><Reference><Citation>Herlands RA, William J, Hershberg U, Shlomchik MJ. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor b cells at extrafollicular sites. Eur J Immunol (2007) 37:3339&#x2013;51. doi:&#xa0;10.1002/eji.200737752</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200737752</ArticleId><ArticleId IdType="pmc">PMC3516908</ArticleId><ArticleId IdType="pubmed">18034429</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckl-Dorna J, Batista FD. BCR-mediated uptake of antigen linked to TLR9 ligand stimulates b-cell proliferation and antigen-specific plasma cell formation. Blood (2009) 113:3969&#x2013;77. doi:&#xa0;10.1182/blood-2008-10-185421</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-10-185421</ArticleId><ArticleId IdType="pubmed">19144984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, O&#x2019;Neill P, Naradikian MS, Scholz JL, Cancro MP. A b-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood (2011) 118:1294&#x2013;304. doi:&#xa0;10.1182/blood-2011-01-330530</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-330530</ArticleId><ArticleId IdType="pmc">PMC3152496</ArticleId><ArticleId IdType="pubmed">21562046</ArticleId></ArticleIdList></Reference><Reference><Citation>Naradikian MS, Hao Y, Cancro MP. Age-associated b cells: key mediators of both protective and autoreactive humoral responses. Immunol Rev (2016) 269:118&#x2013;29. doi:&#xa0;10.1111/imr.12380</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12380</ArticleId><ArticleId IdType="pubmed">26683149</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfc;ndel K, Green NM, Shaffer AL, Moody KL, Busto P, Eilat D, et al. . Cell-intrinsic expression of TLR9 in autoreactive b cells constrains BCR/TLR7-dependent responses. J Immunol (2015) 194:2504&#x2013;12. doi:&#xa0;10.4049/jimmunol.1402425</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1402425</ArticleId><ArticleId IdType="pmc">PMC4382804</ArticleId><ArticleId IdType="pubmed">25681333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai B, Chang SH, Becker EB, Bonni A, Xia Z. p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at ser-65. J Biol Chem (2006) 281:25215&#x2013;22. doi:&#xa0;10.1074/jbc.M512627200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M512627200</ArticleId><ArticleId IdType="pubmed">16818494</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton TM, Rincon M. Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci (2009) 5:44&#x2013;51. doi:&#xa0;10.7150/ijbs.5.44</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.5.44</ArticleId><ArticleId IdType="pmc">PMC2610339</ArticleId><ArticleId IdType="pubmed">19159010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickerson KM, Christensen SR, Cullen JL, Meng W, Prak ETL, Shlomchik MJ. TLR9 promotes tolerance by restricting survival of anergic anti-DNA b cells, yet is also required for their activation. J Immunol (2013) 190:1447&#x2013;56. doi:&#xa0;10.4049/jimmunol.1202115</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202115</ArticleId><ArticleId IdType="pmc">PMC3563726</ArticleId><ArticleId IdType="pubmed">23296704</ArticleId></ArticleIdList></Reference><Reference><Citation>Hondowicz BD, Alexander ST, Quinn WJ, 3rd, Pag&#xe1;n AJ, Metzgar MH, Cancro MP, et al. . The role of BLyS/BLyS receptors in anti-chromatin b cell regulation. Int Immunol (2007) 19:465&#x2013;75. doi:&#xa0;10.1093/intimm/dxm011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxm011</ArticleId><ArticleId IdType="pubmed">17369193</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, Akira S. TLR signaling pathways. Semin Immunol (2004) 16:3&#x2013;9. doi:&#xa0;10.1016/j.smim.2003.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2003.10.003</ArticleId><ArticleId IdType="pubmed">14751757</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian C, Cao X. Regulation of toll-like receptor signaling pathways in innate immune responses. Ann N Y Acad Sci (2013) 1283:67&#x2013;74. doi:&#xa0;10.1111/j.1749-6632.2012.06786.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2012.06786.x</ArticleId><ArticleId IdType="pubmed">23163321</ArticleId></ArticleIdList></Reference><Reference><Citation>Georg I, D&#xed;az-Barreiro A, Morell M, Pey AL, Alarc&#xf3;n-Riquelme ME. BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in b cells. Cell Mol Immunol (2020) 17:954&#x2013;65. doi:&#xa0;10.1038/s41423-019-0254-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-019-0254-9</ArticleId><ArticleId IdType="pmc">PMC7608278</ArticleId><ArticleId IdType="pubmed">31243359</ArticleId></ArticleIdList></Reference><Reference><Citation>Etoh T, Kim YP, Ohsaki A, Komiyama K, Hayashi M. Inhibitory effect of erythraline on toll-like receptor signaling pathway in RAW264.7 cells. Biol Pharm Bull (2013) 36:1363&#x2013;9. doi:&#xa0;10.1248/bpb.b12-00910</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b12-00910</ArticleId><ArticleId IdType="pubmed">23902980</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Liu Y, Li T, Wang P, Mo X, Lv P, et al. . CMTM7 plays key roles in TLR-induced plasma cell differentiation and p38 activation in murine b-1 b cells. Eur J Immunol (2020) 50:809&#x2013;21. doi:&#xa0;10.1002/eji.201948363</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201948363</ArticleId><ArticleId IdType="pubmed">32022930</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, et al. . DOCK8 functions as an adaptor that links TLR-MyD88 signaling to b cell activation. Nat Immunol (2012) 13:612&#x2013;20. doi:&#xa0;10.1038/ni.2305</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2305</ArticleId><ArticleId IdType="pmc">PMC3362684</ArticleId><ArticleId IdType="pubmed">22581261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee NK, Hamerman JA. &#x3b2;(2) integrins inhibit TLR responses by regulating NF-&#x3ba;B pathway and p38 MAPK activation. Eur J Immunol (2013) 43:779&#x2013;92. doi:&#xa0;10.1002/eji.201242550</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201242550</ArticleId><ArticleId IdType="pmc">PMC3809911</ArticleId><ArticleId IdType="pubmed">23310953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, et al. . RNA-Associated autoantigens activate b cells by combined b cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med (2005) 202:1171&#x2013;7. doi:&#xa0;10.1084/jem.20050630</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050630</ArticleId><ArticleId IdType="pmc">PMC2213226</ArticleId><ArticleId IdType="pubmed">16260486</ArticleId></ArticleIdList></Reference><Reference><Citation>Otipoby KL, Waisman A, Derudder E, Srinivasan L, Franklin A, Rajewsky K. The b-cell antigen receptor integrates adaptive and innate immune signals. Proc Natl Acad Sci U.S.A. (2015) 112:12145&#x2013;50. doi:&#xa0;10.1073/pnas.1516428112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1516428112</ArticleId><ArticleId IdType="pmc">PMC4593120</ArticleId><ArticleId IdType="pubmed">26371314</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino AC, Dang VD, Lampropoulou V, Welle A, Joedicke J, Pohar J, et al. . LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells. Immunity (2018) 49:120&#x2013;33.e9. doi:&#xa0;10.1016/j.immuni.2018.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.06.007</ArticleId><ArticleId IdType="pmc">PMC6057275</ArticleId><ArticleId IdType="pubmed">30005826</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernasconi NL, Onai N, Lanzavecchia A. A role for toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive b cells and constitutive expression in memory b cells. Blood (2003) 101:4500&#x2013;4. doi:&#xa0;10.1182/blood-2002-11-3569</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-11-3569</ArticleId><ArticleId IdType="pubmed">12560217</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, et al. . Expansion of toll-like receptor 9-expressing b cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum (2006) 54:3601&#x2013;11. doi:&#xa0;10.1002/art.22197</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22197</ArticleId><ArticleId IdType="pubmed">17075805</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbach H, Schickel JN, Cunningham-Rundles C, Conley ME, Reisli I, Franco JL, et al. . CD19 controls toll-like receptor 9 responses in human b cells. J Allergy Clin Immunol (2016) 137:889&#x2013;98.e6. doi:&#xa0;10.1016/j.jaci.2015.08.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.08.040</ArticleId><ArticleId IdType="pmc">PMC4783287</ArticleId><ArticleId IdType="pubmed">26478008</ArticleId></ArticleIdList></Reference><Reference><Citation>Korganow AS, Knapp AM, Nehme-Schuster H, Soulas-Sprauel P, Poindron V, Pasquali JL, et al. . Peripheral b cell abnormalities in patients with systemic lupus erythematosus in quiescent phase: decreased memory b cells and membrane CD19 expression. J Autoimmun (2010) 34:426&#x2013;34. doi:&#xa0;10.1016/j.jaut.2009.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2009.11.002</ArticleId><ArticleId IdType="pubmed">19963348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol (2000) 165:6635&#x2013;43. doi:&#xa0;10.4049/jimmunol.165.11.6635</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.165.11.6635</ArticleId><ArticleId IdType="pubmed">11086109</ArticleId></ArticleIdList></Reference><Reference><Citation>Culton DA, Nicholas MW, Bunch DO, Zhen QL, Kepler TB, Dooley MA, et al. . Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of b-cell tolerance loss. J Clin Immunol (2007) 27:53&#x2013;68. doi:&#xa0;10.1007/s10875-006-9051-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-006-9051-1</ArticleId><ArticleId IdType="pubmed">17195045</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieudonn&#xe9; Y, Gies V, Guffroy A, Keime C, Bird AK, Liesveld J, et al. . Transitional b cells in quiescent SLE: an early checkpoint imprinted by IFN. J Autoimmun (2019) 102:150&#x2013;8. doi:&#xa0;10.1016/j.jaut.2019.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.05.002</ArticleId><ArticleId IdType="pmc">PMC6642027</ArticleId><ArticleId IdType="pubmed">31085070</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zelm MC, Reisli I, van der Burg M, Casta&#xf1;o D, van Noesel CJ, van Tol MJ, et al. . An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med (2006) 354:1901&#x2013;12. doi:&#xa0;10.1056/NEJMoa051568</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa051568</ArticleId><ArticleId IdType="pubmed">16672701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, Rogers JL, Monteith AJ, Jiang C, Schmitz J, Clarke SH, et al. . Apoptotic debris accumulates on hematopoietic cells and promotes disease in murine and human systemic lupus erythematosus. J Immunol (2016) 196:4030&#x2013;9. doi:&#xa0;10.4049/jimmunol.1500418</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500418</ArticleId><ArticleId IdType="pmc">PMC4868781</ArticleId><ArticleId IdType="pubmed">27059595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri C, Bosma A. Immune regulatory function of b cells. Annu Rev Immunol (2012) 30:221&#x2013;41. doi:&#xa0;10.1146/annurev-immunol-020711-074934</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-074934</ArticleId><ArticleId IdType="pubmed">22224776</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosseau C, Durand M, Colas L, Durand E, Foureau A, Cheminant MA, et al. . CD9(+) regulatory b cells induce T cell apoptosis via IL-10 and are reduced in severe asthmatic patients. Front Immunol (2018) 9:3034. doi:&#xa0;10.3389/fimmu.2018.03034</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03034</ArticleId><ArticleId IdType="pmc">PMC6308143</ArticleId><ArticleId IdType="pubmed">30622536</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles K, Heaney J, Sibinska Z, Salter D, Savill J, Gray D, et al. . A tolerogenic role for toll-like receptor 9 is revealed by b-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci USA (2012) 109:887&#x2013;92. doi:&#xa0;10.1073/pnas.1109173109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109173109</ArticleId><ArticleId IdType="pmc">PMC3271931</ArticleId><ArticleId IdType="pubmed">22207622</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon M, Blair PA, Isenberg DA, Mauri C. A regulatory feedback between plasmacytoid dendritic cells and regulatory b cells is aberrant in systemic lupus erythematosus. Immunity (2016) 44:683&#x2013;97. doi:&#xa0;10.1016/j.immuni.2016.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.012</ArticleId><ArticleId IdType="pmc">PMC4803914</ArticleId><ArticleId IdType="pubmed">26968426</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelka K, Bertheloot D, Reimer E, Phulphagar K, Schmidt SV, Christ A, et al. . The chaperone UNC93B1 regulates toll-like receptor stability independently of endosomal TLR transport. Immunity (2018) 48:911&#x2013;22.e7. doi:&#xa0;10.1016/j.immuni.2018.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.04.011</ArticleId><ArticleId IdType="pmc">PMC6482051</ArticleId><ArticleId IdType="pubmed">29768176</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano S, Morimoto S, Suzuki S, Watanabe T, Amano H, Takasaki Y. Up-regulation of the endoplasmic reticulum transmembrane protein UNC93B in the b cells of patients with active systemic lupus erythematosus. Rheumatol (Oxford) (2010) 49:876&#x2013;81. doi:&#xa0;10.1093/rheumatology/keq001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keq001</ArticleId><ArticleId IdType="pubmed">20159909</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, et al. . Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci U.S.A. (2009) 106:12061&#x2013;6. doi:&#xa0;10.1073/pnas.0905441106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905441106</ArticleId><ArticleId IdType="pmc">PMC2715524</ArticleId><ArticleId IdType="pubmed">19574451</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh YT, Scatizzi JC, Gahan JD, Lawson BR, Baccala R, Pollard KM, et al. . Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing b cells. J Immunol (2013) 190:4982&#x2013;90. doi:&#xa0;10.4049/jimmunol.1202986</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202986</ArticleId><ArticleId IdType="pmc">PMC3729324</ArticleId><ArticleId IdType="pubmed">23589617</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui R, Saitoh S, Kanno A, Onji M, Shibata T, Ito A, et al. . Unc93B1 restricts systemic lethal inflammation by orchestrating toll-like receptor 7 and 9 trafficking. Immunity (2011) 35:69&#x2013;81. doi:&#xa0;10.1016/j.immuni.2011.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.010</ArticleId><ArticleId IdType="pubmed">21683627</ArticleId></ArticleIdList></Reference><Reference><Citation>Desnues B, Macedo AB, Roussel-Queval A, Bonnardel J, Henri S, Demaria O, et al. . TLR8 on dendritic cells and TLR9 on b cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice. Proc Natl Acad Sci U.S.A. (2014) 111:1497&#x2013;502. doi:&#xa0;10.1073/pnas.1314121111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314121111</ArticleId><ArticleId IdType="pmc">PMC3910605</ArticleId><ArticleId IdType="pubmed">24474776</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer O, Liu B, Kreuk LSM, Krogan N, Barton GM. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature (2019) 575:366&#x2013;70. doi:&#xa0;10.1038/s41586-019-1612-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1612-6</ArticleId><ArticleId IdType="pmc">PMC6856441</ArticleId><ArticleId IdType="pubmed">31546246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature (2008) 452:234&#x2013;8. doi:&#xa0;10.1038/nature06726</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06726</ArticleId><ArticleId IdType="pubmed">18305481</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz LX, Lee J, Kapoor U, Kartnig F, Sedlyarov V, Papakostas K, et al. . TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature (2020) 581:316&#x2013;22. doi:&#xa0;10.1038/s41586-020-2282-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2282-0</ArticleId><ArticleId IdType="pmc">PMC7610944</ArticleId><ArticleId IdType="pubmed">32433612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Shimabukuro-Demoto S, Yoshida-Sugitani R, Furuyama-Tanaka K, Karyu H, Sugiura Y, et al. . The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. Immunity (2014) 41:375&#x2013;88. doi:&#xa0;10.1016/j.immuni.2014.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.08.011</ArticleId><ArticleId IdType="pubmed">25238095</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasius AL, Arnold CN, Georgel P, Rutschmann S, Xia Y, Lin P, et al. . Slc15a4, AP-3, and hermansky-pudlak syndrome proteins are required for toll-like receptor signaling in plasmacytoid dendritic cells. Proc Natl Acad Sci USA (2010) 107:19973&#x2013;8. doi:&#xa0;10.1073/pnas.1014051107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014051107</ArticleId><ArticleId IdType="pmc">PMC2993408</ArticleId><ArticleId IdType="pubmed">21045126</ArticleId></ArticleIdList></Reference><Reference><Citation>Baccala R, Gonzalez-Quintial R, Blasius AL, Rimann I, Ozato K, Kono DH, et al. . Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc Natl Acad Sci USA (2013) 110:2940&#x2013;5. doi:&#xa0;10.1073/pnas.1222798110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222798110</ArticleId><ArticleId IdType="pmc">PMC3581947</ArticleId><ArticleId IdType="pubmed">23382217</ArticleId></ArticleIdList></Reference><Reference><Citation>Domeier PP, Chodisetti SB, Schell SL, Kawasawa YI, Fasnacht MJ, Soni C, et al. . B-cell-intrinsic type 1 interferon signaling is crucial for loss of tolerance and the development of autoreactive b cells. Cell Rep (2018) 24:406&#x2013;18. doi:&#xa0;10.1016/j.celrep.2018.06.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.046</ArticleId><ArticleId IdType="pmc">PMC6089613</ArticleId><ArticleId IdType="pubmed">29996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, et al. . Plasmacytoid dendritic cells control TLR7 sensitivity of naive b cells via type I IFN. J Immunol (2005) 174:4043&#x2013;50. doi:&#xa0;10.4049/jimmunol.174.7.4043</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.7.4043</ArticleId><ArticleId IdType="pubmed">15778362</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni C, Perez OA, Voss WN, Pucella JN, Serpas L, Mehl J, et al. . Plasmacytoid dendritic cells and type I interferon promote extrafollicular b cell responses to extracellular self-DNA. Immunity (2020) 52:1022&#x2013;38.e7. doi:&#xa0;10.1016/j.immuni.2020.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.015</ArticleId><ArticleId IdType="pmc">PMC7306002</ArticleId><ArticleId IdType="pubmed">32454024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C, Wang J, Fagerberg E, Chen PM, Connolly KA, Damo M, et al. . Neoantigen-driven b cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell (2021) 184:6101&#x2013;18.e13. doi:&#xa0;10.1016/j.cell.2021.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.007</ArticleId><ArticleId IdType="pmc">PMC8671355</ArticleId><ArticleId IdType="pubmed">34852236</ArticleId></ArticleIdList></Reference><Reference><Citation>Naradikian MS, Myles A, Beiting DP, Roberts KJ, Dawson L, Herati RS, et al. . Cutting edge: IL-4, IL-21, and IFN-&#x3b3; interact to govern T-bet and CD11c expression in TLR-activated b cells. J Immunol (2016) 197:1023&#x2013;8. doi:&#xa0;10.4049/jimmunol.1600522</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600522</ArticleId><ArticleId IdType="pmc">PMC4975960</ArticleId><ArticleId IdType="pubmed">27430719</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjorton K, Hagberg N, Israelsson E, Jinton L, Berggren O, Sandling JK, et al. . Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor. Arthritis Res Ther (2018) 20:238. doi:&#xa0;10.1186/s13075-018-1702-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1702-0</ArticleId><ArticleId IdType="pmc">PMC6235225</ArticleId><ArticleId IdType="pubmed">30355354</ArticleId></ArticleIdList></Reference><Reference><Citation>Corzo CA, Varfolomeev E, Setiadi AF, Francis R, Klabunde S, Senger K, et al. . The kinase IRAK4 promotes endosomal TLR and immune complex signaling in b cells and plasmacytoid dendritic cells. Sci Signal (2020) 13:eaaz1053. doi:&#xa0;10.1126/scisignal.aaz1053</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aaz1053</ArticleId><ArticleId IdType="pubmed">32487715</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler A, Sun W, De S, Jiao A, Sharif MN, Symanowicz PT, et al. . The interleukin-1 receptor-associated kinase 4 inhibitor PF-06650833 blocks inflammation in preclinical models of rheumatic disease and in humans enrolled in a randomized clinical trial. Arthritis Rheumatol (2021) 73:2206&#x2013;18. doi:&#xa0;10.1002/art.41953</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41953</ArticleId><ArticleId IdType="pmc">PMC8671219</ArticleId><ArticleId IdType="pubmed">34423919</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanda SK, Lopez-Pelaez M, Arthur JS, Marchesi F, Cohen P. Suppression of IRAK1 or IRAK4 catalytic activity, but not type 1 IFN signaling, prevents lupus nephritis in mice expressing a ubiquitin binding-defective mutant of ABIN1. J Immunol (2016) 197:4266&#x2013;73. doi:&#xa0;10.4049/jimmunol.1600788</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600788</ArticleId><ArticleId IdType="pmc">PMC5114882</ArticleId><ArticleId IdType="pubmed">27807192</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarneo SA, Hughes PF, Yang KW, Carlson DA, Gurbani D, Westover KD, et al. . A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase. J Biol Chem (2020) 295:1565&#x2013;74. doi:&#xa0;10.1074/jbc.RA119.011857</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.011857</ArticleId><ArticleId IdType="pmc">PMC7008364</ArticleId><ArticleId IdType="pubmed">31914413</ArticleId></ArticleIdList></Reference><Reference><Citation>Port A, Shaw JV, Klopp-Schulze L, Bytyqi A, Vetter C, Hussey E, et al. . Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8. Pharmacol Res Perspect (2021) 9:e00842. doi:&#xa0;10.1002/prp2.842</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.842</ArticleId><ArticleId IdType="pmc">PMC8377444</ArticleId><ArticleId IdType="pubmed">34414672</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopp-Schulze L, Shaw JV, Dong JQ, Khandelwal A, Vazquez-Mateo C, Goteti K. Applying modeling and simulations for rational dose selection of novel toll-like receptor 7/8 inhibitor enpatoran for indications of high medical need. Clin Pharmacol Ther (2022) 112:297&#x2013;306. doi:&#xa0;10.1002/cpt.2606</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2606</ArticleId><ArticleId IdType="pmc">PMC9540480</ArticleId><ArticleId IdType="pubmed">35390178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamphier M, Zheng W, Latz E, Spyvee M, Hansen H, Rose J, et al. . Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo. Mol Pharmacol (2014) 85:429&#x2013;40. doi:&#xa0;10.1124/mol.113.089821</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.113.089821</ArticleId><ArticleId IdType="pubmed">24342772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacre K, Criswell LA, McCune JM. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther (2012) 14:R155. doi:&#xa0;10.1186/ar3895</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3895</ArticleId><ArticleId IdType="pmc">PMC3446541</ArticleId><ArticleId IdType="pubmed">22734582</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy RM, Markham AJ, Buyon JP. Endosomal toll-like receptors in clinically overt and silent autoimmunity. Immunol Rev (2016) 269:76&#x2013;84. doi:&#xa0;10.1111/imr.12383</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12383</ArticleId><ArticleId IdType="pmc">PMC4685960</ArticleId><ArticleId IdType="pubmed">26683146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohme M, Maisonneuve L, Achour K, Dussiot M, Maschalidi S, Manoury B. TLR7 trafficking and signaling in b cells is regulated by the MHCII-associated invariant chain. J Cell Sci (2020) 133:jcs236711. doi:&#xa0;10.1242/jcs.236711</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.236711</ArticleId><ArticleId IdType="pubmed">32079661</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya M, Sokolovska A, Tam JM, Conway KL, Stefani C, Raso F, et al. . &#x3b1;v integrins combine with LC3 and atg5 to regulate toll-like receptor signalling in b cells. Nat Commun (2016) 7:10917. doi:&#xa0;10.1038/ncomms10917</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10917</ArticleId><ArticleId IdType="pmc">PMC4792966</ArticleId><ArticleId IdType="pubmed">26965188</ArticleId></ArticleIdList></Reference><Reference><Citation>Raso F, Sagadiev S, Du S, Gage E, Arkatkar T, Metzler G, et al. . &#x3b1;v integrins regulate germinal center b cell responses through noncanonical autophagy. J Clin Invest (2018) 128:4163&#x2013;78. doi:&#xa0;10.1172/jci99597</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci99597</ArticleId><ArticleId IdType="pmc">PMC6118577</ArticleId><ArticleId IdType="pubmed">29999501</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer O, Liu B, Woo BJ, Kreuk LSM, Van Dis E, Barton GM. Release from UNC93B1 reinforces the compartmentalized activation of select TLRs. Nature (2019) 575:371&#x2013;4. doi:&#xa0;10.1038/s41586-019-1611-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1611-7</ArticleId><ArticleId IdType="pmc">PMC6856438</ArticleId><ArticleId IdType="pubmed">31546247</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev (2018) 281:8&#x2013;27. doi:&#xa0;10.1111/imr.12621</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12621</ArticleId><ArticleId IdType="pmc">PMC5756628</ArticleId><ArticleId IdType="pubmed">29247995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. . Systemic lupus erythematosus. Nat Rev Dis Primers (2016) 2:16039. doi:&#xa0;10.1038/nrdp.2016.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson DS, Pang J, Weir A, Kong IY, Fritsch M, Rashidi M, et al. . Interferon-&#x3b3; primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway. Immunity (2022) 55:423&#x2013;41.e9. doi:&#xa0;10.1016/j.immuni.2022.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8822620</ArticleId><ArticleId IdType="pubmed">35139355</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>